Sahajanand Medical Technologies Limited

Sahajanand Medical Technologies (NEW IPO): GMP, Profit, Price & expert review

by

Sahajanand Medical Technologies Limited is an R&D-driven medical device manufacturer specializing in advanced cardiovascular devices such as coronary stents, balloons, and structural heart solutions. The company focuses on vascular intervention and structural heart treatments, with its products used in hospitals across more than 70 countries.

Sahajanand Medical Technologies Limited supplies its products to75+ countries worldwide, supplying hospitals and cardiology centres globally. It holds~25% market share in India’s Drug-Eluting Stent (DES) segment by sales volume. It develops and manufactures cardiovascular medical devices, mainly coronary stents, balloon catheters, trans-catheter aortic valves (TAVI) and occluders used in vascular and structural heart treatments.

Sahajanand Medical Technologies Limited has filed DRHP with the Securities and Exchange Board of India (SEBI) to initiate an Initial Public Offering (IPO) consisting entirely as an Offer-for-Sale (OFS) of 27,644,231 Equity Shares by existing investors.

 Subscription date to apply for Sahajanand Medical Technologies Limited is yet to be announced. Price band for the IPO is yet to be declared.

Check DRHP
Check IPO Allotment
Visit Official Website
Issue Size:27,644,231 Equity shares
Fresh Issue:NA
Offer for Sale:27,644,231 Equity shares
Price Range:TBA
Lot Size:TBA
GMPPending

Sahajanand Medical Technologies Limited important data points

Revenue, PAT, EBITDA

YearFiscal 2025
Networth₹ 545.23 Cr
Revenue:₹ 1024.87 Cr
EBITDA₹ 128.02 Cr
EBITDA Margin:~12.49%
PAT₹ 25.15 Cr
PAT Margin~2.45%
Face Value:₹ 1

IPO important dates

Open Date:TBA
Close Date:TBA
Anchor Investor BiddingTBA
Allotment Date:TBA
Refunds & Demat CreditTBA
Tentative Listing Date:TBA

Use of Proceeds

PurposeAmount
Expansion of manufacturing facilityN/A
Working capital requirementsN/A
Sales and MarketingN/A
General Corporate PurposeN/A

Sahajanand Medical Technologies Limited Financial Data

202320242025
Revenue (₹ Cr)₹ 795.54₹ 901.6₹ 1024.87
PAT (₹ Cr)₹ 11.93₹ -7.35₹ 25.15
Asset (₹ Cr)₹ 911.6₹ 970.57₹ 1094.89
Net Worth (₹ Cr)₹ 539.21₹ 526.3₹ 545.23

Sahajanand Medical Technologies IPO Grey Market Premium

DateIPO PriceIPO GMPProfit per lot
02-May₹ –₹ –₹ –
01-May₹ –₹ –₹ –
30-Apr₹ –₹ –₹ –
29-Apr₹ –₹ –₹ –
28-Apr₹ –₹ –₹ –
Sahajanand Medical Technologies Limited

Sahajanand Medical Technologies Limited IPO Pros & Cons

Strengths:

  • Strong presence in cardiovascular medical devices with focus on high-demand drug-eluting stents and heart intervention products.
  • Wide global footprint with sales in 75+ countries, diversifying revenue sources.
  • Established brand in India’s stent market with significant market share in the DES segment.
  • Continuous R&D and innovation pipeline including structural heart devices like TAVI.
  • Growing global demand for minimally invasive cardiac treatments supporting long-term growth.

Risks:

  • IPO is entirely Offer for Sale (OFS), meaning the company will not receive fresh capital.
  • Business depends heavily on cardiovascular product segment, creating product concentration risk.
  • Highly regulated medical device industry with strict approvals and compliance requirements.
  • Strong competition from global players like Abbott Laboratories and Medtronic.
  • Exposure to pricing regulations and government controls on stents in India.

Sahajanand Medical Technologies Limited
Promoters – Pre offer equity (Approx)

Promoters%Shares
Shree Hari Trust~ 36.79 %
Dhirajkumar Savjibhai Vasoya~ 4.03 %
Sahajanand Technologies Private Limited~ 0.06 %
Jitendra Vallabhbhai Kotadia~ 0.03 %

Sahajanand Medical Technologies Limited Promoters – Pre offer equity (Approx)

Application TypeLot SizeNo. of LotNo. of SharesInvestment Amount
Retail (Min)–1–₹ –
Retail (Max)–13–₹ –
HNI (Min)–14–₹ –
HNI (Max)–66–₹ –
Big HNI (Min)–67–₹ –

Lead Managers / Registrars of Sahajanand Medical Technologies Limited

Lead / Book Running Lead ManagersMotilal Oswal Investment Advisors Limited,
Avendus Capital Private Limited,
HSBC Securities and Capital Markets (India) Private Limited,
Nuvama Wealth Management Limited
Registrar (RTA)MUFG Intime India Pvt Ltd

FAQ’S of Sahajanand Medical Technologies Limited

  • It develops and manufactures advanced cardiovascular medical devices like coronary stents, balloons, valves and occluders used for vascular intervention and structural heart treatments globally.

  • The IPO is mainly an Offer For Sale (OFS) to enable existing investors to unlock value and list the company publicly.

  • The issue size of the IPO comprises entirely an OFS of ~2.76 Cr equity shares. It will be listed on BSE and NSE platform.

  • Key risks include dependence on cardiovascular products, strict regulatory approvals in medical devices, pricing controls on stents, and strong competition from global medical technology companies.

  • The company benefits from strong R&D, global presence in 70+ countries, growing demand for minimally invasive cardiac treatments, and increasing adoption of advanced medical devices.

  • Investors can apply for the IPO through ASBA via net banking or using UPI through registered stock brokers once the IPO opens for subscription.

  • Toggle Content

For more amazing blogs click here (IPO Corner).

Leave a comment